Skip to content

Minimally Invasive Hypoglossal Nerve Stimulation Study (Lingual Study)

Minimally Invasive Hypoglossal Nerve Stimulation Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03210142
Acronym
Lingual
Enrollment
23
Registered
2017-07-06
Start date
2017-06-23
Completion date
2018-07-31
Last updated
2018-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea, Obstructive

Keywords

Sleep Apnea, Neural Stimulation

Brief summary

The purpose of this study is to assess the effect of Transvenous Hypoglossal Nerve Stimulation (tHGNS) on tongue position in the upper airway. Activation of the HGN will cause contraction of the genioglossus muscle, which will move the tongue forward, opening the upper-airway and reducing apnea-hypopnea events in patients with Obstructive Sleep Apnea (OSA). A transvenous approach will be less risky and traumatic than current HGNS systems that require an open surgical approach to wrap a cuff electrode around the HGN.

Detailed description

The primary objective is to determine the effect of tHGNS on tongue position in the upper airway in subjects undergoing an EP, cardiac catheterization or device procedure. (Measured as changes in the anteroposterior dimensions (2-dimensional) of the retropalatal and retrolingual airway spaces.) This will be an acute study lasting no more than 45 min during a standard new device implant, cardiac catheterization and/or EP procedure. The hypoglossal nerve will be stimulated from the lingual vein using various stimulation parameters. Tongue motion, upper airway opening or any side effects will be recorded. At the end of the test procedure all hardware - the catheters, lead and/or guide wire will be removed.

Interventions

PROCEDURETransvenous hypoglossal nerve stimulation

Transvenous hypoglossal nerve stimulation to open upper airway.

Sponsors

Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is at least 18 years old * Subject is undergoing a standard new device implant, cardiac catheterization involving right heart catheterization and/or EP procedures * Subject is able and willing to give informed consent

Exclusion criteria

* Subject is unable or unwilling to participate with study procedures * Subject is pregnant (all women with childbearing potential must have a negative pregnancy test within 7 days prior to enrollment) * Subject is known to be allergic to radio opaque dye * Subject has a body mass index (BMI) \>40 kg/m2 * Subject has had prior neck surgery that may interfere with vascular access to the lingual vein * Subject has had prior surgery of the oral cavity that may interfere with tongue or soft palate movement * Subject has a significant upper airway-related anatomic anomaly * Subject is enrolled in a concurrent study that may confound the results of this study.

Design outcomes

Primary

MeasureTime frameDescription
Effect of transvenous hypoglossal nerve stimulation on tongue positionDuring study procedureMeasured in changes in the anteroposterior dimensions (2-dimensional) of the retropalatal and retrolingual airway spaces from lateral fluoroscopic images.

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026